FLT3 p.D835E
About
Gene context: FLT3
Biomarker Type: Somatic Variant
Present: True
Chromosome: 13
Start Position: 28592640
End Position: 28592640
Reference Allele: A
Alternate Allele: C
Cdna Change: c.2505T>G
Protein Change: p.D835E
Variant Annotation: Missense
Exon: 20
Rsid: rs121913487
Hgvsg: 13:g.28592640A>C
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | FLT3 p.D835E | Acute Lymphoid Leukemia | Gilteritinib | |
| FDA (1) | FLT3 p.D835E | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Midostaurin |